CIR SPA: directors' dealings · Italy · Consob

About CIR SPA

CIR S.p.A. – Compagnie Industriali Riunite is an Italian industrial holding company listed on Borsa Italiana (FTSE MIB) in Italy. The company is historically associated with the De Benedetti family and has long been known for a capital-allocation model focused on value creation, portfolio optimization, and disciplined asset management rather than on a single pure-play industrial franchise. CIR’s historical headquarters are in Milan, and the group states that it still owns the building at via Ciovassino 1, which remains an emblematic address for the company. From an operating standpoint, CIR is now centered on two main pillars: healthcare, through KOS, and automotive components, through Sogefi. KOS is one of Italy’s leading long-term care operators, with a network of facilities serving elderly patients, rehabilitation needs, and broader social-healthcare services. CIR describes KOS as one of the principal Italian players in the sector, with an international footprint that also includes Germany. Sogefi is active in automotive components and aftermarket solutions, with product lines tied to systems used in internal combustion, hybrid, and electric vehicles. Over the past few years, the group has also accelerated portfolio reshaping at Sogefi as part of its strategic transition. CIR’s competitive position comes less from scale leadership and more from capital allocation, restructuring capability, and the ability to monetize assets or subsidiaries when strategic conditions are favorable. The company aims to generate cash flow, dividends, and long-term revaluation across its portfolio. In 2024, the group reported €1.821 billion in revenues, 15,054 employees across 14 countries, and 13,777 beds within KOS facilities. Those figures underscore a mid-sized but diversified platform with a defensive healthcare component and an industrial exposure that remains selective. Recent milestones include the sale in 2024 of a non-core real estate property in Milan, which strengthened the balance sheet, and the disposal of Sogefi’s Filtration division, a transaction aimed at reducing exposure to businesses less aligned with e-mobility technologies. In 2025, CIR announced an agreement to acquire F2i Healthcare’s 40.23% stake in KOS, a strategically significant step that increases CIR’s control over its healthcare platform. For investors, CIR offers a listed Italian holding-company profile with exposure to healthcare resilience, industrial turnaround optionality, and active balance-sheet management on Borsa Italiana (FTSE MIB) in Italy.